Latest Redmile Group, LLC Stock Portfolio
$1.49Billion | No. of Holdings #39
Redmile Group, LLC Performance
2026 Q2+18.34%
YTD+18.54%
2025+39.74%
About Redmile Group, LLC and 13F Hedge Fund Stock Holdings
On 2026-08-14, the fund reported it's updated stock portfolio. In the 13F Holdings report, Redmile Group, LLC reported an equity portfolio of $1.5 Billions as of 30 Jun, 2026. <br><br> The top stock holdings of Redmile Group, LLC are SRRK, KRYS, STOK. The fund has invested 15.9% of it's portfolio in SCHOLAR ROCK HLDG CORP and 15.8% of portfolio in KRYSTAL BIOTECH INC. <br><br> They significantly reduced their stock positions in SCHOLAR ROCK HLDG CORP (SRRK), NURIX THERAPEUTICS INC (NRIX) and COGENT BIOSCIENCES INC (COGT). Redmile Group, LLC opened new stock positions in CLIMB BIO INC (ELYM), AURA BIOSCIENCES INC (AURA) and ODYSSEY THERAPEUTICS INC. The fund showed a lot of confidence in some stocks as they added substantially to AGOMAB THERAPEUTICS NV, CELLDEX THERAPEUTICS INC NEW (CLDX) and BIOMARIN PHARMACEUTICAL INC (BMRN).
Redmile Group, LLC Equity Portfolio Value
Last Reported on: 14 Aug, 2026
$1.49Billion
as of Aug 14, 2026Redmile Group, LLC Annual Return Estimates Vs S&P 500
Our best estimate is that Redmile Group, LLC made a return of 18.34% in the last quarter. In trailing 12 months, it's portfolio return was 97.06%.
- Performance
- S&P 500
New Buys
| Ticker | $ Bought |
|---|---|
| climb bio inc | 15,991,300 |
| aura biosciences inc | 11,833,300 |
| odyssey therapeutics inc | 7,951,750 |
| insmed inc | 5,462,570 |
New stocks bought by Redmile Group, LLC
Additions
| Ticker | % Inc. |
|---|---|
| agomab therapeutics nv | 1,649 |
| celldex therapeutics inc new | 65.93 |
| biomarin pharmaceutical inc | 52.52 |
| shattuck labs inc | 24.41 |
| ideaya biosciences inc | 22.85 |
Additions to existing portfolio by Redmile Group, LLC
Reductions
| Ticker | % Reduced |
|---|---|
| scholar rock hldg corp | -52.45 |
| nurix therapeutics inc | -47.32 |
| cogent biosciences inc | -26.85 |
| adc therapeutics sa | -25.49 |
| annexon inc | -18.42 |
| absci corporation | -18.34 |
| dbv technologies s a | -16.47 |
| livanova plc | -14.03 |
Redmile Group, LLC reduced stake in above stock
Sold off
None of the stocks were completely sold off by Redmile Group, LLC
Sector Distribution
Redmile Group, LLC has about 89.5% of it's holdings in Healthcare sector.
- Healthcare
- Others
| Sector | % |
|---|---|
| Healthcare | 89.5 |
| Others | 10.3 |
Market Cap. Distribution
Redmile Group, LLC has about 17.2% of it's portfolio invested in the large-cap and mega-cap stocks.
- MID-CAP
- SMALL-CAP
- LARGE-CAP
- UNALLOCATED
- MICRO-CAP
| Category | % |
|---|---|
| MID-CAP | 39.8 |
| SMALL-CAP | 27.8 |
| LARGE-CAP | 17.2 |
| UNALLOCATED | 10.3 |
| MICRO-CAP | 5 |
Stocks belong to which Index?
About 69.7% of the stocks held by Redmile Group, LLC either belong to S&P 500 or RUSSELL 2000 index.
- RUSSELL 2000
- Others
| Index | % |
|---|---|
| RUSSELL 2000 | 69.7 |
| Others | 30.3 |
Redmile Group, LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Redmile Group, LLC
Redmile Group, LLC has 39 stocks in it's portfolio. About 73.5% of the portfolio is in top 10 stocks. ADCT proved to be the most loss making stock for the portfolio. KRYS was the most profitable stock for Redmile Group, LLC last quarter.
$1.49BTotal Value
39.00Positions
14 Aug, 2026Last Reported
| Expand | Holdingsorted ascending | % Portfolio | Shares Held | $ Value | % Change |
|---|---|---|---|---|---|
 Absci Corporation Redmile Group, LLC's holding in Absci Corporation over time | 5.24% | 6,739,680 | $78.11M 5.24% | 18.34%decreased 18.34 percentreduced | |
 ADCT Adc Therapeutics SaAdc Therapeutics SaADCT | 0.83% | 11,526,700 | $12.33M 0.83% | 25.49%decreased 25.49 percentreduced | |
 Invivyd Inc Invivyd IncADGI Redmile Group, LLC's holding in Invivyd Inc over time | 0.15% | 2,597,760 | $2.27M 0.15% | 1.92%decreased 1.92 percentreduced | |
 Alx Oncology Hldgs Inc Redmile Group, LLC's holding in Alx Oncology Hldgs Inc over time | 1.03% | 7,392,500 | $15.30M 1.03% | 7.18%decreased 7.18 percentreduced | |
 Annexon Inc Annexon IncANNX Redmile Group, LLC's holding in Annexon Inc over time | 4.55% | 11,869,900 | $67.78M 4.55% | 18.42%decreased 18.42 percentreduced | |
 Ardelyx Inc Ardelyx IncARDX Redmile Group, LLC's holding in Ardelyx Inc over time | 0.22% | 641,750 | $3.27M 0.22% | 12.49%decreased 12.49 percentreduced | |
 Atara Biotherapeutics Inc Redmile Group, LLC's holding in Atara Biotherapeutics Inc over time | 0.34% | 441,701 | $5.07M 0.34% | 0%unchanged 0 percentunchanged | |
 Aura Biosciences Inc Redmile Group, LLC's holding in Aura Biosciences Inc over time | 0.79% | 1,666,670 | $11.83M 0.79% | Newnew position | |
 Beam Therapeutics Inc Redmile Group, LLC's holding in Beam Therapeutics Inc over time | 2.68% | 1,164,260 | $39.96M 2.68% | 5.93%decreased 5.93 percentreduced | |
 Biomarin Pharmaceutical Inc Redmile Group, LLC's holding in Biomarin Pharmaceutical Inc over time | 1.02% | 265,169 | $15.17M 1.02% | 52.52%increased 52.52 percentadded | |
 Celldex Therapeutics Inc New Redmile Group, LLC's holding in Celldex Therapeutics Inc New over time | 1.08% | 433,921 | $16.15M 1.08% | 65.93%increased 65.93 percentadded | |
 Cogent Biosciences Inc Redmile Group, LLC's holding in Cogent Biosciences Inc over time | 1.31% | 503,321 | $19.48M 1.31% | 26.85%decreased 26.85 percentreduced | |
 DBVT Dbv Technologies S ADbv Technologies S ADBVT | 0.45% | 410,440 | $6.73M 0.45% | 16.47%decreased 16.47 percentreduced | |
 Climb Bio Inc Climb Bio IncELYM Redmile Group, LLC's holding in Climb Bio Inc over time | 1.07% | 1,226,330 | $15.99M 1.07% | Newnew position | |
 Establishment Labs Hldgs Inc Redmile Group, LLC's holding in Establishment Labs Hldgs Inc over time | 0.51% | 88,964 | $7.63M 0.51% | 14.01%decreased 14.01 percentreduced | |
 Fate Therapeutics Inc Redmile Group, LLC's holding in Fate Therapeutics Inc over time | 2.33% | 12,872,900 | $34.76M 2.33% | 0%unchanged 0 percentunchanged | |
 Ideaya Biosciences Inc Redmile Group, LLC's holding in Ideaya Biosciences Inc over time | 1.6% | 640,202 | $23.86M 1.6% | 22.85%increased 22.85 percentadded | |
 Immunome Inc Immunome IncIMNM Redmile Group, LLC's holding in Immunome Inc over time | 6.99% | 4,911,590 | $104.08M 6.99% | 11.64%decreased 11.64 percentreduced | |
 Insmed Inc Insmed IncINSM Redmile Group, LLC's holding in Insmed Inc over time | 0.37% | 51,234 | $5.46M 0.37% | Newnew position | |
 Krystal Biotech Inc Redmile Group, LLC's holding in Krystal Biotech Inc over time | 15.77% | 632,005 | $234.90M 15.77% | 6.16%decreased 6.16 percentreduced | |